Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change $ Change
grade C $247.03 0.29% 0.71
AGN closed up 0.29 percent on Thursday, February 23, 2017, on 50 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical AGN trend table...

Date Alert Name Type % Chg
Feb 17 NR7 Range Contraction 0.15%
Feb 17 Narrow Range Bar Range Contraction 0.15%
Feb 16 Bearish Engulfing Bearish 0.32%
Feb 16 Slingshot Bullish Bullish Swing Setup 0.32%
Feb 15 Doji - Bearish? Reversal -0.64%
Feb 14 180 Bullish Setup Bullish Swing Setup -0.34%
Feb 10 NR7 Range Contraction 0.56%
Feb 8 180 Bullish Setup Bullish Swing Setup 2.72%
Feb 6 New Uptrend Bullish 5.67%
Feb 2 Doji - Bearish? Reversal 7.93%

Older signals for AGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 298.26
52 Week Low 183.98
Average Volume 3,893,328
200-Day Moving Average 226.97
50-Day Moving Average 218.22
20-Day Moving Average 235.54
10-Day Moving Average 246.45
Average True Range 5.19
ADX 48.24
+DI 30.99
-DI: 9.06
Chandelier Exit (Long, 3 ATRs) 234.66
Chandelier Exit (Short, 3 ATRs) 224.29
Upper Bollinger Band 261.68
Lower Bollinger Band 209.4
Percent B (%b) 0.71
Bandwidth 0.221921